About Ectosense
Ectosense is a Healthcare company based in Leuven (Belgium) founded in 2015 by Frederik Massie, and was acquired by ResMed in October 2021. It operates in the Healthcare and Technology sectors. Ectosense has raised $1.91 million across 2 funding rounds from investors including ResMed, Saffelberg Investments and imec.istart. The company has 1 employees. Its Indian entity Ectosense India Private Limited reported revenue of ₹1.40 Cr. Ectosense offers products and services including NightOwl Sensor and NightOwl Companion App. Its focus areas include Life Sciences, Sleep Medicine, Medical Device and Screening.
Company details
Provider of connected solutions for monitoring sleep disorders. The device is called NightOwl, which is used in home-based sleep apnea tests.
- Headquarters Leuven, Belgium
- Employees 1
- Founders Frederik Massie
- Stage Acquired
- SectorsHealthcareTechnology
- Website ectosense.com
- Social LinkedIn X Facebook
- Acquired by ResMed (Oct 2021)
- Legal Name Ectosense India Private Limited
- Date of Incorporation 06 Aug, 2020
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹1.40 Cr
FY 2022 · +533% YoY
- Indian entity net profit₹13.5 Lakh
FY 2022 · 10% margin
- Indian entity EBITDA₹19.1 Lakh
FY 2022 · 14% margin
- Total Equity Funding$1.91M (USD)
in 2 rounds
- Latest Funding Round$1.85M (USD), Seed
Mar 2018
- InvestorsResMed
& 2 more
- Employee Count1
- Acquired byResMed
(Oct 2021)
Associated legal entities of Ectosense
Ectosense operates through Ectosense India Private Limited (dissolved under section 59(8)). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ectosense India Private Limited CIN U72500KA2020FTC136955 | Dissolved Under Section 59(8) | 06 Aug 2020 | Bangalore, Karnataka | ₹1.4 Cr | 2 | View details |
Products & Services of Ectosense
Ectosense offers a comprehensive portfolio of products and services, including NightOwl Sensor and NightOwl Companion App.
Device for monitoring patient health data remotely.
App for managing and accessing sensor data.
Funding Insights of Ectosense
Ectosense has successfully raised a total of $1.91M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.85 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.91M
- Total Rounds 2
- Last Round Seed — $1.85M
- First Round $54,435
(Jun 2015)
- Investors Count 2
All 2 funding rounds of Ectosense with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2018 | $1.85M | Seed | – | Saffelberg Investments | – |
| Jun 2015 | $54,435 | Seed | – | – |
3 investors in total: 3 institutional.
Investors in Ectosense
Ectosense has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include ResMed, Saffelberg Investments and imec.istart.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| saffelberg.com | ||||
Funding solutions for tech startups are provided by the accelerator. | imecistart.com | Ghent, Belgium | ||
Therapeutic devices to treat sleep apnea and respiratory disorders | 1989 | resmed.com | San Diego, United States |
Investor details for Ectosense
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Ectosense India Private Limited (Ectosense)
Ectosense India Private Limited is the primary company behind Ectosense. The board of Ectosense India Private Limited currently have 2 directors; the longest-serving is Ashish Kumar Matta, appointed in 2021. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashish Kumar Matta DIN 07890861 | Director | 01 Oct 2021 | 5 yrs 1 mo | Ectosense India Private Limited |
| Seema Arora DIN 06912826 | Director | 19 Jul 2022 | 4 yrs 3 mo | Ectosense India Private Limited |
People of Ectosense
1 people are tracked at Ectosense (1 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CTO | Leadership |
Complete people profiles for Ectosense
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Ectosense
Figures of Ectosense India Private Limited, the primary company behind Ectosense, for FY 2022. Revenue was ₹1.40 Cr (+533% year on year). Net profit was ₹13.5 Lakh (10% margin). EBITDA was ₹19.1 Lakh (14% margin).
- ₹1.40 CrRevenue · FY 2022 · +533% YoY
- ₹13.5 LakhNet profit · 10% margin
- ₹19.1 LakhEBITDA · 14% margin
- ₹25 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Ectosense India Private Limited are on its company page.
Detailed financial statements for Ectosense
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Ectosense
4 dated milestones of Ectosense across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Ectosense is founded.
- Funding First funding round of $54K.
- Funding Latest funding round, Seed, of $1.9M.
- Exit Acquired by ResMed.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ectosense
Complete news archive for Ectosense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ectosense
Ectosense was founded in 2015.
Ectosense is headquartered in Leuven, Belgium. It is registered at Leuven, Flemish Brabant, Belgium.
Ectosense is a funded company, having raised a total of $1.91M across 2 funding rounds to date. The company's 1st funding round was a Seed of $54.44K, raised on Jun 2015.
Ectosense has 1 employees.
The primary company behind Ectosense, Ectosense India Private Limited, reported revenue of ₹1.40 Cr for FY 2022, up 533% year on year.
Provider of connected solutions for monitoring sleep disorders. The device is called NightOwl, which is used in home-based sleep apnea tests.
Ectosense offers NightOwl Sensor and NightOwl Companion App.
Ectosense has 3 investors. Key investors include ResMed, Saffelberg Investments, and imec.istart.
Ectosense operates through Ectosense India Private Limited.
Yes. Ectosense was acquired by ResMed in October 2021.
The legal entities of Ectosense currently have 2 directors, including Seema Arora, Ashish Kumar Matta.